Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vanda Pharmaceuticals (NQ: VNDA )

4.660 +0.010 (+0.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Other Filings

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Form 8-K
Source: SEC/Edgar
April 12, 2018
Form 424B5
Source: SEC/Edgar
March 15, 2018
Form 8-K
Source: SEC/Edgar
March 15, 2018
Form 8-K
Source: SEC/Edgar
March 13, 2018
Form 424B5
Source: SEC/Edgar
March 13, 2018
Form 8-K
Source: SEC/Edgar
March 04, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Form 8-K
Source: SEC/Edgar
February 13, 2018
Form SC 13G
Source: SEC/Edgar
February 08, 2018
Form SC 13G/A
Source: SEC/Edgar
January 18, 2018
Form 8-K
Source: SEC/Edgar
January 07, 2018
Form 8-K
Source: SEC/Edgar
October 17, 2017
Form 8-K
Source: SEC/Edgar
August 01, 2017
Form SC 13G/A
Source: SEC/Edgar
July 09, 2017
Form SC 13G
Source: SEC/Edgar
June 18, 2017
Form 8-K
Source: SEC/Edgar
March 12, 2017
Form 8-K
Source: SEC/Edgar
March 05, 2017
Form SC 13G
Source: SEC/Edgar
February 16, 2017
Form SC 13G
Source: SEC/Edgar
February 15, 2017
Form 8-K
Source: SEC/Edgar
February 14, 2017
Form SC 13G/A
Source: SEC/Edgar
February 13, 2017
Form SC 13G/A
Source: SEC/Edgar
February 13, 2017
Form SC 13G/A
Source: SEC/Edgar
February 13, 2017
Form SC 13G/A
Source: SEC/Edgar
January 26, 2017
Form SC 13G/A
Source: SEC/Edgar
January 12, 2017
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.